Moderna
MRNA
#1709
Rank
โ‚ฌ8.38 B
Marketcap
21,68ย โ‚ฌ
Share price
-1.89%
Change (1 day)
-77.63%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Revenue for Moderna (MRNA)

Revenue in 2024 (TTM): โ‚ฌ2.94 Billion

According to Moderna 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ2.80 Billion. a decrease over the revenue in the year 2023 that were of โ‚ฌ6.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Moderna from 2018 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ3.07 B-49.68%
2023 โ‚ฌ6.10 B-65.28%
2022 โ‚ฌ17.59 B12.36%
2021 โ‚ฌ15.66 B6920.58%
2020 โ‚ฌ0.22 B420.22%
2019 โ‚ฌ42.88 M-60.04%
2018 โ‚ฌ0.10 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.30 B 1,905.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.07 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.97 B-29.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ45.38 B 1,516.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ2.19 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ77.93 B 2,676.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.16 B-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA